BNIPL antibody (Middle Region)
Quick Overview for BNIPL antibody (Middle Region) (ABIN928647)
Target
See all BNIPL AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Purification
- Purified
-
Immunogen
- BNIPL antibody was raised in rabbit using the middle region of BNIPL as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
BNIPL Blocking Peptide, (ABIN936528), is also available for use as a blocking control in assays to test for specificity of this BNIPL antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- BNIPL (BCL2/adenovirus E1B 19kD Interacting Protein Like (BNIPL))
-
Alternative Name
- BNIPL
-
Background
- BNIPL may be a bridge molecule between BCL2 and ARHGAP1/CDC42 in promoting cell death. Synonyms: Polyclonal BNIPL antibody, Anti-BNIPL antibody, BCL2/adenovirus E1B 19kD interacting protein like antibody, BNIP-S antibody, BNIPL-1 antibody, BNIPL-2 antibody, PP753 antibody.
Target
-